it allows for thorough correction and cartilage restoration. Non-surgical management remains foundational in early and mild cases and includes activity modification, physical therapy focusing on hip strength and flexibility, anti-inflammatory medications, and occasionally intra-articular injections of corticosteroids or biologic agents like platelet-rich plasma (PRP) or stem cells, although the long-term efficacy of the latter remains under investigation. The goals of hip preservation extend beyond the physical aspect, incorporating quality of life, functional goals, and psychological well-being, as hip pain can significantly hinder mobility, athletic participation, and daily activities, particularly in younger individuals who may otherwise be expected to maintain an active lifestyle for decades.

Innovations in diagnostic tools, such as 3D imaging and motion analysis, are enhancing our understanding of hip mechanics and aiding in the customization of treatment plans, ensuring more precise interventions and better outcomes. arthroscopy, advancements in surgical techniques, postoperative rehabilitation protocols, and biologic augmentation are expanding the scope and success rate of hip preservation. Research continues to identify patient-specific factors that influence outcomes, including age, activity level, joint morphology, and cartilage health, and the emerging role of genetics and molecular biology may eventually guide more personalized interventions. A multidisciplinary team including orthopaedic surgeons, physical therapists, radiologists, sports medicine physicians, and sometimes rheumatologists is often required to optimize care, particularly in borderline cases or those with overlapping pathologies like ligamentum teres injuries, snapping hip syndrome, or coexisting spine issues.

Despite these advances, challenges remain, such as accurately predicting which patients will benefit from preservation versus those who are better served with early arthroplasty, as well as addressing failed preservation surgeries, which may complicate future joint replacement procedures. Longitudinal studies and registry data are essential for tracking outcomes, identifying best practices, and refining indications, while patient education and shared decision-making remain central to treatment planning, ensuring that expectations align with realistic goals. Hip preservation has also become an important area of focus in pediatric and adolescent orthopaedics, particularly in conditions like slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes disease, and developmental dysplasia of the hip (DDH), where early recognition and timely intervention can influence long-term joint health and function.

In the sports world, where peak performance and joint longevity are critical, hip preservation offers athletes a means to address injuries without sacrificing their careers, and return-to-play protocols are increasingly guided by objective criteria and functional assessments. As our population remains active longer into life, the relevance of hip preservation continues to grow, offering an alternative to traditional hip replacement, which, while highly successful, comes with limitations including prosthesis lifespan, revision surgery risks, and activity restrictions. In conclusion, hip preservation represents a dynamic and holistic approach aimed at understanding, preventing, and treating the root causes of hip pain and dysfunction, with the goal of sustaining natural joint health and maximizing patient function across the lifespan.